Vaccinex (NASDAQ: VCNX) reported Q3 EPS of ($1.09), $0.83 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $20 thousand versus the consensus estimate of $0 .

For earnings history and earnings-related data on Vaccinex (VCNX) click here.